GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

GeneFerm Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	275.46	122.45	120.15	100.69	539.61	348.02
Cash & Short-Term Investments	275.46	122.45	120.15	100.69	539.61	348.02
Cash Growth	101.35%	1.91%	19.33%	-81.34%	55.05%	-18.36%
Accounts Receivable	91.36	101.56	117.6	120.98	104.66	71.15
Other Receivables	15.92	15.22	0.15	0.46	0.24	2.72
Receivables	107.28	116.78	117.75	121.44	104.9	73.87
Inventory	179.55	165.87	155.43	142.61	114.83	109.52
Prepaid Expenses	6.75	6.87	3.8	8.81	5.84	4.17
Total Current Assets	569.04	411.97	397.13	373.54	765.18	535.58
Property, Plant & Equipment	668.36	708.46	761.95	734.28	510.39	421.45
Other Intangible Assets	1.29	1.7	2.02	1.1	1.4	1.23
Long-Term Deferred Tax Assets	11.23	14.37	8.87	8.66	7.7	7.19
Other Long-Term Assets	7.56	9.99	5.41	72.05	32.22	17.13
Total Assets	1,257	1,146	1,175	1,190	1,317	982.58
Accounts Payable	19.76	23.77	33.2	49.93	39.08	23.86
Accrued Expenses	47.82	46.71	58.39	51.9	40.95	32.46
Short-Term Debt	-	-	40	45	-	-
Current Portion of Long-Term Debt	33.16	24.43	5.25	26	308.65	37.67
Current Portion of Leases	4.44	5.42	6.04	5.97	5.19	5.39
Current Income Taxes Payable	-	-	19.01	10.28	13.42	-
Current Unearned Revenue	19.46	12.49	5.78	7.63	8.29	6.96
Other Current Liabilities	22.52	21.43	22.18	42.52	15.6	9.5
Total Current Liabilities	147.15	134.26	189.86	239.22	431.18	115.85
Long-Term Debt	213.67	126.54	-	5.25	31.25	359.91
Long-Term Leases	76.46	78.53	76.15	98.8	92.13	96.87
Pension & Post-Retirement Benefits	19.73	18.88	16.52	15.59	14.66	13.75
Long-Term Deferred Tax Liabilities	0.06	0.1	-	-	-	-
Other Long-Term Liabilities	0.01	0.01	0.01	0.01	0.01	0.01
Total Liabilities	457.08	358.31	282.54	358.86	569.22	586.38
Common Stock	414.6	414.6	414.6	414.6	407.89	278.93
Additional Paid-In Capital	294.34	294.34	294.34	294.34	270.69	102.01
Retained Earnings	94.4	81.38	186.69	124.26	72.27	18.24
Comprehensive Income & Other	-2.95	-2.13	-2.79	-2.43	-3.19	-3
Shareholders' Equity	800.39	788.18	892.84	830.77	747.66	396.19
Total Liabilities & Equity	1,257	1,146	1,175	1,190	1,317	982.58
Total Debt	327.72	234.92	127.44	181.02	437.22	499.83
Net Cash (Debt)	-52.27	-112.47	-7.29	-80.33	102.39	-151.81
Net Cash Per Share	-1.26	-2.71	-0.18	-1.89	2.21	-5.44
Filing Date Shares Outstanding	41.46	41.46	41.46	41.46	40.79	27.89
Total Common Shares Outstanding	41.46	41.46	41.46	41.46	40.79	27.89
Working Capital	421.89	277.71	207.27	134.32	334	419.73
Book Value Per Share	19.31	19.01	21.53	20.04	18.33	14.20
Tangible Book Value	799.09	786.48	890.82	829.67	746.27	394.97
Tangible Book Value Per Share	19.27	18.97	21.49	20.01	18.30	14.16
Land	15.44	15.44	15.44	15.44	15.44	15.44
Buildings	457.57	457.26	260.87	259.44	255.46	223.32
Machinery	831.11	825.29	822.26	725.62	536.67	503.51
Construction In Progress	0.61	-	194.02	184.12	127.34	64.74

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.